Reference Citation Analysis: Find an Article, Find a Category, Find a Journal, Find a Scholar

Citation(s) in RCA

1
(from Reference Citation Analysis)

Indexed Articles

Ranked By

Results Analysis

Year Published Analysis
Article Type Analysis
Journal Title Analysis
Category Analysis

Results Analysis

Year Published

Show more Refine

Article Statistics

Refine

Publication Titles

Show more Refine

Category

Show more Refine

For: Almajed S, Alotaibi N, Zulfiqar S, Dhuhaibawi Z, O'Rourke N, Gaule R, Byrne C, Barry AM, Keeley D, O'Mahony JF. Cost-effectiveness evidence on approved cancer drugs in Ireland: the limits of data availability and implications for public accountability. Eur J Health Econ 2022;23:375-431. [PMID: 34460007 PMCID: PMC8964600 DOI: 10.1007/s10198-021-01365-2] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 09/11/2020] [Accepted: 07/29/2021] [Indexed: 06/13/2023]

For:	Almajed S, Alotaibi N, Zulfiqar S, Dhuhaibawi Z, O'Rourke N, Gaule R, Byrne C, Barry AM, Keeley D, O'Mahony JF. Cost-effectiveness evidence on approved cancer drugs in Ireland: the limits of data availability and implications for public accountability. Eur J Health Econ 2022;23:375-431. [PMID: 34460007 PMCID: PMC8964600 DOI: 10.1007/s10198-021-01365-2] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 09/11/2020] [Accepted: 07/29/2021] [Indexed: 06/13/2023]

Number	Cited by Other Article(s)
1	Wen J, Li M, Jiang Y. Cost effectiveness of innovative anti-cancer drugs and reimbursement decisions in China. HEALTH POLICY AND TECHNOLOGY 2023. [DOI: 10.1016/j.hlpt.2023.100742] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 03/29/2023] Abstract Collapse Key Words Collapse MESH Headings Collapse Grants Collapse Affiliation(s) Collapse

Number

Cited by Other Article(s)

Wen J, Li M, Jiang Y. Cost effectiveness of innovative anti-cancer drugs and reimbursement decisions in China. HEALTH POLICY AND TECHNOLOGY 2023. [DOI: 10.1016/j.hlpt.2023.100742] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 03/29/2023]